Search hospitals

>

New York

>

Bronx

Montefiore Medical Center - Moses Campus

Claim this profile

Bronx, New York 10467

Global Leader in Cancer

Global Leader in Lung Cancer

Conducts research for Breast Cancer

Conducts research for Breast cancer

Conducts research for Brain Tumor

363 reported clinical trials

30 medical researchers

Photo of Montefiore Medical Center - Moses Campus in BronxPhoto of Montefiore Medical Center - Moses Campus in BronxPhoto of Montefiore Medical Center - Moses Campus in Bronx

Summary

Montefiore Medical Center - Moses Campus is a medical facility located in Bronx, New York. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Breast cancer, Brain Tumor and other specialties. Montefiore Medical Center - Moses Campus is involved with conducting 363 clinical trials across 581 conditions. There are 30 research doctors associated with this hospital, such as Lisa Gennarini, MD, Nitin Ohri, Benjamin A. Gartrell, and Azeem Latib, MD.

Area of expertise

1

Cancer

Global Leader

Montefiore Medical Center - Moses Campus has run 65 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Lung Cancer

Global Leader

Montefiore Medical Center - Moses Campus has run 53 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage III

Top PIs

Clinical Trials running at Montefiore Medical Center - Moses Campus

Lung Cancer

Cancer

Breast Cancer

Skin Cancer

Brain Tumor

Small Cell Lung Cancer

Breast cancer

Prostate Cancer

Melanoma

Colorectal Cancer

Image of trial facility.

Thoracotomy vs Thoracoscopy

for Metastatic Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Proton Craniospinal Radiation

for Cancer in the Brain and Spinal Cord

This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.

Recruiting

2 awards

Phase 3

3 criteria

Image of trial facility.

Durvalumab

for Lung Cancer

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.

Recruiting

2 awards

Phase 3

8 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Montefiore Medical Center - Moses Campus?

Where is Montefiore Medical Center - Moses Campus located?

Who should I call to ask about financial aid or insurance network?

What insurance does Montefiore Medical Center - Moses Campus accept?

What awards or recognition has Montefiore Medical Center - Moses Campus received?